Vice President, Market Access


Responsible for assisting international clients understand the early implications of evidence for access considerations, alongside regulatory and clinical development activities, with a particular focus on proposing creative and pragmatic solutions.


  • Strategic and operational generation of health outcomes and real-world evidence in the context of health technology assessments (HTA) and reimbursement submissions
  • Patient access, pricing and reimbursement for medications, devices, and other health products, particularly for rare diseases or atypical health technologies
  • Extensive network of market access experts


  • Clinician with inpatients’ and outpatients’ care experience – 22 years of experience in healthcare
  • 18 years of market access experience in its wide definition
  • Client-side experience in pharmaceutical and medical device
  • 11 years of consulting experience
Publications & Webinars